• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸参数可预测慢性阻塞性肺疾病(COPD)患者(GOLD 2017 B级)的不良预后。

Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B.

作者信息

Brat Kristian, Plutinsky Marek, Hejduk Karel, Svoboda Michal, Popelkova Patrice, Zatloukal Jaromir, Volakova Eva, Fecaninova Miroslava, Heribanova Lucie, Koblizek Vladimir

机构信息

Department of Respiratory Diseases, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.

Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.

出版信息

Int J Chron Obstruct Pulmon Dis. 2018 Mar 26;13:1037-1052. doi: 10.2147/COPD.S147262. eCollection 2018.

DOI:10.2147/COPD.S147262
PMID:29628761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5877495/
Abstract

BACKGROUND

Respiratory parameters are important predictors of prognosis in the COPD population. Global Initiative for Obstructive Lung Disease (GOLD) 2017 Update resulted in a vertical shift of patients across COPD categories, with category B being the most populous and clinically heterogeneous. The aim of our study was to investigate whether respiratory parameters might be associated with increased all-cause mortality within GOLD category B patients.

METHODS

The data were extracted from the Czech Multicentre Research Database, a prospective, noninterventional multicenter study of COPD patients. Kaplan-Meier survival analyses were performed at different levels of respiratory parameters (partial pressure of oxygen in arterial blood [PaO], partial pressure of arterial carbon dioxide [PaCO] and greatest decrease of basal peripheral capillary oxygen saturation during 6-minute walking test [6-MWT]). Univariate analyses using the Cox proportional hazard model and multivariate analyses were used to identify risk factors for mortality in hypoxemic and hypercapnic individuals with COPD.

RESULTS

All-cause mortality in the cohort at 3 years of prospective follow-up reached 18.4%. Chronic hypoxemia (PaO <7.3 kPa), hypercapnia (PaCO >7.0 kPa) and oxygen desaturation during the 6-MWT were predictors of long-term mortality in COPD patients with forced expiratory volume in 1 second ≤60% for the overall cohort and for GOLD B category patients. Univariate analyses confirmed the association among decreased oxemia (<7.3 kPa), increased capnemia (>7.0 kPa), oxygen desaturation during 6-MWT and mortality in the studied groups of COPD subjects. Multivariate analysis identified PaO <7.3 kPa as a strong independent risk factor for mortality.

CONCLUSION

Survival analyses showed significantly increased all-cause mortality in hypoxemic and hypercapnic GOLD B subjects. More important, PaO <7.3 kPa was the strongest risk factor, especially in category B patients. In contrast, the majority of the tested respiratory parameters did not show a difference in mortality in the GOLD category D cohort.

摘要

背景

呼吸参数是慢性阻塞性肺疾病(COPD)患者预后的重要预测指标。《慢性阻塞性肺疾病全球倡议》(GOLD)2017年更新版导致各COPD类别患者出现垂直转移,其中B类患者数量最多且临床异质性最强。我们研究的目的是调查呼吸参数是否可能与GOLD B类患者全因死亡率增加相关。

方法

数据取自捷克多中心研究数据库,这是一项针对COPD患者的前瞻性、非干预性多中心研究。在不同呼吸参数水平(动脉血氧分压[PaO]、动脉血二氧化碳分压[PaCO]以及6分钟步行试验[6-MWT]期间基础外周毛细血管血氧饱和度的最大降幅)进行了Kaplan-Meier生存分析。使用Cox比例风险模型进行单因素分析,并进行多因素分析以确定COPD低氧血症和高碳酸血症患者的死亡风险因素。

结果

前瞻性随访3年时,队列中的全因死亡率达到18.4%。慢性低氧血症(PaO<7.3 kPa)、高碳酸血症(PaCO>7.0 kPa)以及6-MWT期间的氧饱和度下降是1秒用力呼气量≤60%的COPD患者总体队列和GOLD B类患者长期死亡的预测指标。单因素分析证实了低氧血症(<7.3 kPa)降低、高碳酸血症(>7.0 kPa)增加、6-MWT期间氧饱和度下降与所研究的COPD受试者组死亡率之间的关联。多因素分析确定PaO<7.3 kPa是死亡的强有力独立风险因素。

结论

生存分析显示,GOLD B类低氧血症和高碳酸血症患者的全因死亡率显著增加。更重要的是,PaO<7.3 kPa是最强的风险因素,尤其是在B类患者中。相比之下,大多数测试的呼吸参数在GOLD D类队列的死亡率中未显示出差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/2439bbaf73d2/copd-13-1037Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/a83d931edfd0/copd-13-1037Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/8ec7f0eff2c0/copd-13-1037Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/339ddc17f335/copd-13-1037Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/2439bbaf73d2/copd-13-1037Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/a83d931edfd0/copd-13-1037Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/8ec7f0eff2c0/copd-13-1037Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/339ddc17f335/copd-13-1037Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/5877495/2439bbaf73d2/copd-13-1037Fig4.jpg

相似文献

1
Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B.呼吸参数可预测慢性阻塞性肺疾病(COPD)患者(GOLD 2017 B级)的不良预后。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 26;13:1037-1052. doi: 10.2147/COPD.S147262. eCollection 2018.
2
Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia.慢性高碳酸血症型慢性阻塞性肺疾病患者的生存率可通过吸烟习惯、合并症和低氧血症来预测。
Chest. 2005 Jun;127(6):1904-10. doi: 10.1378/chest.127.6.1904.
3
Severity of acidosis affects long-term survival in COPD patients with hypoxemia after intensive care unit discharge.酸中毒的严重程度影响慢性阻塞性肺疾病(COPD)合并低氧血症患者在重症监护病房出院后的长期生存。
Int J Chron Obstruct Pulmon Dis. 2018 May 9;13:1495-1506. doi: 10.2147/COPD.S159504. eCollection 2018.
4
Efficacy of long-term noninvasive positive pressure ventilation in stable hypercapnic COPD patients with respiratory failure: a meta-analysis of randomized controlled trials.长期无创正压通气对稳定期高碳酸血症型慢性阻塞性肺疾病呼吸衰竭患者的疗效:一项随机对照试验的荟萃分析
Int J Chron Obstruct Pulmon Dis. 2017 Oct 10;12:2977-2985. doi: 10.2147/COPD.S148422. eCollection 2017.
5
Exercise response to oxygen supplementation is not associated with survival in hypoxemic patients with obstructive lung disease.对于患有阻塞性肺病的低氧血症患者,补充氧气后的运动反应与生存率无关。
Int J Chron Obstruct Pulmon Dis. 2018 May 17;13:1607-1612. doi: 10.2147/COPD.S163119. eCollection 2018.
6
Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.慢性阻塞性肺疾病急性加重患者入院时游离DNA水平的预后效用
Int J Chron Obstruct Pulmon Dis. 2016 Dec 9;11:3153-3161. doi: 10.2147/COPD.S113256. eCollection 2016.
7
Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.基于心肺运动试验为晚期慢性阻塞性肺疾病患者提供个性化的肺康复和职业治疗。
Int J Chron Obstruct Pulmon Dis. 2015 Sep 3;10:1787-800. doi: 10.2147/COPD.S86455. eCollection 2015.
8
Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study.低碳酸血症和高碳酸血症预测氧依赖慢性阻塞性肺疾病患者的死亡率:一项基于人群的前瞻性研究。
Respir Res. 2014 Mar 13;15(1):30. doi: 10.1186/1465-9921-15-30.
9
Improvement in hypercapnia does not predict survival in COPD patients on chronic noninvasive ventilation.高碳酸血症的改善并不能预测慢性无创通气的慢性阻塞性肺疾病(COPD)患者的生存率。
Int J Chron Obstruct Pulmon Dis. 2018 Nov 1;13:3625-3634. doi: 10.2147/COPD.S169951. eCollection 2018.
10
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.富氧高流量鼻导管治疗对慢性低氧性呼吸衰竭慢性阻塞性肺疾病患者的长期影响。
Int J Chron Obstruct Pulmon Dis. 2018 Apr 16;13:1195-1205. doi: 10.2147/COPD.S159666. eCollection 2018.

引用本文的文献

1
Predictors of Clinical Stability and Mortality in COPD: A Longitudinal Study.慢性阻塞性肺疾病临床稳定性和死亡率的预测因素:一项纵向研究。
Int J Chron Obstruct Pulmon Dis. 2025 Jul 7;20:2311-2324. doi: 10.2147/COPD.S531435. eCollection 2025.
2
Poor treatment outcomes of acute exacerbations of chronic obstructive pulmonary disease and their associated factors among admitted patients in East Gojjam, 2023.2023年东戈贾姆地区住院患者慢性阻塞性肺疾病急性加重的治疗效果不佳及其相关因素
Front Med (Lausanne). 2024 Nov 20;11:1434166. doi: 10.3389/fmed.2024.1434166. eCollection 2024.
3
Prognostic Properties of the GOLD 2023 Classification System.

本文引用的文献

1
Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.中东欧有吸烟史的慢性阻塞性肺疾病患者的表型:教皇研究
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.01446-2016. Print 2017 May.
2
GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.《慢性阻塞性肺疾病全球倡议2017》迈向基于表型的方法?来自中东欧慢性阻塞性肺疾病表型(POPE)队列的分析
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.02518-2016. Print 2017 Apr.
3
Mechanisms of hypoxemia.
2023 年 GOLD 分类系统的预后特征。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 20;18:661-667. doi: 10.2147/COPD.S410372. eCollection 2023.
4
Use of Laboratory Tests and Their Prognostic Value in Patients with Stable Chronic Obstructive Pulmonary Disease.稳定期慢性阻塞性肺疾病患者的实验室检查及其预后价值。
Mo Med. 2022 Nov-Dec;119(6):545-552.
5
Cellular mechanisms involved in the pathogenesis of airway remodeling in chronic lung disease.慢性肺病气道重塑发病机制中的细胞机制。
Eur Clin Respir J. 2022 Jul 8;9(1):2097377. doi: 10.1080/20018525.2022.2097377. eCollection 2022.
6
COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD.COPD 下呼吸道感染视觉模拟评分(c-LRTI-VAS)在稳定期和加重期 COPD 患者中的验证。
BMJ Open Respir Res. 2021 Feb;8(1). doi: 10.1136/bmjresp-2020-000761.
7
Development in PaCO over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.COPD 合并持续性高碳酸血症呼吸衰竭患者经高流量鼻导管治疗 12 个月后 PaCO2 的变化:一项随机对照试验的事后分析。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000712.
8
Hypercapnia-Driven Skeletal Muscle Dysfunction in an Animal Model of Pulmonary Emphysema Suggests a Complex Phenotype.肺气肿动物模型中高碳酸血症驱动的骨骼肌功能障碍提示一种复杂表型。
Front Physiol. 2020 Oct 29;11:600290. doi: 10.3389/fphys.2020.600290. eCollection 2020.
9
Impact of Hyponatremia on COPD Exacerbation Prognosis.低钠血症对慢性阻塞性肺疾病急性加重预后的影响。
J Clin Med. 2020 Feb 12;9(2):503. doi: 10.3390/jcm9020503.
10
AMP-Activated Protein Kinase (AMPK) at the Crossroads Between CO Retention and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease (COPD).腺嘌呤核苷酸活化蛋白激酶 (AMPK) 在慢性阻塞性肺疾病 (COPD) 中 CO 潴留与骨骼肌功能障碍的交汇点。
Int J Mol Sci. 2020 Jan 31;21(3):955. doi: 10.3390/ijms21030955.
低氧血症的机制。
Lung India. 2017 Jan-Feb;34(1):47-60. doi: 10.4103/0970-2113.197116.
4
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.一项针对中度低氧慢性阻塞性肺疾病患者长期吸氧的随机试验。
N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344.
5
The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study.体外二氧化碳去除术避免 COPD 患者因急性高碳酸血症呼吸衰竭对无创通气无反应而插管的可行性和安全性(ECLAIR 研究):多中心病例对照研究。
Intensive Care Med. 2016 Sep;42(9):1437-44. doi: 10.1007/s00134-016-4452-y. Epub 2016 Jul 25.
6
Differences in baseline factors and survival between normocapnia, compensated respiratory acidosis and decompensated respiratory acidosis in COPD exacerbation: A pilot study.慢性阻塞性肺疾病急性加重期时,正常碳酸血症、代偿性呼吸性酸中毒和失代偿性呼吸性酸中毒之间的基线因素及生存率差异:一项初步研究。
Respirology. 2016 Jan;21(1):128-36. doi: 10.1111/resp.12652. Epub 2015 Oct 8.
7
The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation.终末期慢性阻塞性肺疾病患者家庭无创通气的成本效益:一项系统评价和经济学评估
Health Technol Assess. 2015 Oct;19(81):1-246. doi: 10.3310/hta19810.
8
The Use of Pulse Oximetry to Determine Hypoxemia in Acute Exacerbations of COPD.使用脉搏血氧饱和度测定法来确定慢性阻塞性肺疾病急性加重期的低氧血症
COPD. 2015;12(6):613-20. doi: 10.3109/15412555.2014.995291. Epub 2015 Mar 16.
9
Czech multicenter research database of severe COPD.捷克重度慢性阻塞性肺疾病多中心研究数据库
Int J Chron Obstruct Pulmon Dis. 2014 Nov 10;9:1265-74. doi: 10.2147/COPD.S71828. eCollection 2014.
10
Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD.动脉血氧张力的系列测量与慢性阻塞性肺疾病的死亡率相关。
COPD. 2015 Jun;12(3):287-94. doi: 10.3109/15412555.2014.948996. Epub 2014 Sep 17.